Timothy Richardson
Affiliations: | 2014 | University of North Texas Health Science Center |
Google:
"Timothy Richardson"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| James W. Simpkins | grad student | 2014 | University of North Texas Health Science Center |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Richardson TE, Kelly HN, Yu AE, et al. (2013) Therapeutic strategies in Friedreich's ataxia. Brain Research. 1514: 91-7 |
| Lincoln KM, Gonzalez P, Richardson TE, et al. (2013) A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders. Chemical Communications (Cambridge, England). 49: 2712-4 |
| Simpkins JW, Richardson TE, Yi KD, et al. (2013) Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy. Hormones and Behavior. 63: 278-83 |
| Lincoln KM, Richardson TE, Rutter L, et al. (2012) An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation. Acs Chemical Neuroscience. 3: 919-27 |
| Richardson TE, Simpkins JW. (2012) R- and S-equol have equivalent cytoprotective effects in Friedreich's ataxia. Bmc Pharmacology & Toxicology. 13: 12 |
| Richardson TE, Yu AE, Wen Y, et al. (2012) Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. Plos One. 7: e34600 |
| Richardson TI, Clarke CA, Yu KL, et al. (2011) Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids. Acs Medicinal Chemistry Letters. 2: 148-53 |
| Richardson TE, Yang SH, Wen Y, et al. (2011) Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology. 152: 2742-9 |
| Richardson T, Yang S, Wen Y, et al. (2011) P4-434: Effects of estrogen in a friedreich's ataxia disease model Alzheimer's & Dementia. 7: e63-e63 |
| Wallace OB, Richardson TI, Dodge JA. (2003) Estrogen receptor modulators: relationships of ligand structure, receptor affinity and functional activity. Current Topics in Medicinal Chemistry. 3: 1663-82 |